Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Froniglutide by ImmunoForge for Inclusion Body Myositis (IBM): Likelihood of Approval
Froniglutide is under clinical development by ImmunoForge and currently in Phase II for Inclusion Body Myositis (IBM). According to GlobalData,...
Froniglutide by ImmunoForge for Polymyositis: Likelihood of Approval
Froniglutide is under clinical development by ImmunoForge and currently in Phase II for Polymyositis. According to GlobalData, Phase II drugs...
Froniglutide by ImmunoForge for Dermatomyositis: Likelihood of Approval
Froniglutide is under clinical development by ImmunoForge and currently in Phase II for Dermatomyositis. According to GlobalData, Phase II drugs...